Beckman Coulter’s SARS-CoV-2 IgG II antibody test approved in countries accepting CE Mark
Beckman Coulter’s Access SARS-CoV-2 IgG II assay is now available in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection. The ability to establish a quantitative baseline to evaluate an individual’s immune response to the SARSCoV- 2 virus […]
